Abstract
Background: After treatment, cancer survivors often experience ongoing psychological anguish and a reduction in their quality of life. This research assesses how psychosocial therapies affect this population's mental health and quality of life (QoL). Methods: There was a 164 cancer survivor randomized controlled trial. Two groups were formed out of them: the psychological intervention group (n = 82) and the control group (n = 82). Over the course of twelve weeks, the approach included scheduled treatment and assistance times. Your progress was measured at the beginning, after 12 weeks, three months, and six months using the “EORTC Quality of Life Questionnaire (QLQ-C30) and the Hospital Anxiety and Depression Scale (HADS)”. Examining changes in QoL, anxiety, and depression using the outcomes helped one understand them. Results: When compared to the control group, the intervention group had a substantial decrease in both anxiety and depression. After a 12-week period, the anxiety and depression ratings dropped to 7.4 (p < 0.001) and 10.5 (p < 0.001), respectively. Notable gains were also seen in quality of life, with global QoL ratings increasing from 62.1 to 75.4 (p < 0.001). Notable improvements in social and emotional functioning as well as decreases in tiredness were seen. Over the course of the follow-up period, these benefits persisted. Conclusion: Psychosocial therapies help cancer survivors' mental health and QoL. Integration of these therapies into routine cancer therapy is important because of the notable and long-lasting advantages in lowering anxiety, despair, and tiredness and improving overall QoL.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call